» Articles » PMID: 28798029

PPARγ in Dendritic Cells and T Cells Drives Pathogenic Type-2 Effector Responses in Lung Inflammation

Overview
Journal J Exp Med
Date 2017 Aug 12
PMID 28798029
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Type-2 immune responses are well-established drivers of chronic inflammatory diseases, such as asthma, and represent a large burden on public health systems. The transcription factor PPARγ is known to promote M2-macrophage and alveolar macrophage development. Here, we report that PPARγ plays a key role in both T cells and dendritic cells (DCs) for development of type-2 immune responses. It is predominantly expressed in mouse Th2 cells in vitro and in vivo as well as human Th2 cells from allergic patients. Using conditional knockouts, we show that PPARγ signaling in T cells, although largely dispensable for IL-4 induction, is critical for IL-33-driven Th2 effector function in type-2 allergic airway responses. Furthermore, we demonstrate that IL-4 and IL-33 promote up-regulation of PPARγ in lung-resident CD11b DCs, which enhances migration to draining lymph nodes and Th2 priming capacity. Thus, we uncover a surprising proinflammatory role for PPARγ and establish it as a novel, important mediator of DC-T cell interactions in type-2 immunity.

Citing Articles

Single-cell and chromatin accessibility profiling reveals regulatory programs of pathogenic Th2 cells in allergic asthma.

Khan M, Alteneder M, Reiter W, Krausgruber T, Dobnikar L, Madern M Nat Commun. 2025; 16(1):2565.

PMID: 40089475 DOI: 10.1038/s41467-025-57590-3.


Tissue-Resident Th2 Cells in Type 2 Immunity and Allergic Diseases.

Mannion J, Rahimi R Immunol Rev. 2025; 330(1):e70006.

PMID: 39981858 PMC: 11897987. DOI: 10.1111/imr.70006.


NFATc1 in CD4 T cells and CD11c dendritic cells drives T2-mediated eosinophilic inflammation in allergic asthma.

Yang Z, Krammer S, Mitlander H, Grund J, Zirlik S, Wirtz S J Allergy Clin Immunol Glob. 2024; 4(1):100355.

PMID: 39629220 PMC: 11613943. DOI: 10.1016/j.jacig.2024.100355.


Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of T2 Cells as Therapeutic Concept in COVID-19 Infection.

Becker A, Rohrich K, Leske A, Heinicke U, Knape T, Kannt A Immunotargets Ther. 2024; 13:595-616.

PMID: 39507298 PMC: 11539866. DOI: 10.2147/ITT.S463601.


NRF2 is a spatiotemporal metabolic hub essential for the polyfunctionality of Th2 cells.

Choi G, Ju H, Bok J, Choi J, Shin J, Oh H Proc Natl Acad Sci U S A. 2024; 121(28):e2319994121.

PMID: 38959032 PMC: 11252815. DOI: 10.1073/pnas.2319994121.


References
1.
Barner M, Mohrs M, Brombacher F, Kopf M . Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr Biol. 1998; 8(11):669-72. DOI: 10.1016/s0960-9822(98)70256-8. View

2.
Wynn T . Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015; 15(5):271-82. DOI: 10.1038/nri3831. View

3.
Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, Sallusto F . Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol. 2002; 4(1):78-86. DOI: 10.1038/ni872. View

4.
Woerly G, Honda K, Loyens M, Papin J, Auwerx J, Staels B . Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J Exp Med. 2003; 198(3):411-21. PMC: 2194090. DOI: 10.1084/jem.20021384. View

5.
Townsend M, Fallon P, Matthews D, Jolin H, McKenzie A . T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med. 2000; 191(6):1069-76. PMC: 2193113. DOI: 10.1084/jem.191.6.1069. View